Pharmaceuticals

Revenue Performance ARS Pharmaceuticals recorded total revenue of $28.1 million for the fourth quarter of 2025, driven largely by $20.3…

Biopharmaceutical company CorMedix Inc. (NASDAQ: CRMD) reported a sharp increase in revenues for the fourth quarter of fiscal 2025, primarily…

Biopharmaceutical company Liquidia Corporation (NASDAQ: LQDA) reported a profit for the fourth quarter of fiscal 2025, compared to a loss…

EyePoint, Inc. (NASDAQ: EYPT), which is engaged in the development of therapeutics for retinal diseases, on Wednesday announced financial results…

Optical retail company National Vision Holdings, Inc. (NASDAQ: EYE) on Wednesday announced financial results for the fourth quarter of FY25,…

Cellectar Biosciences, Inc. (NASDAQ: CLRB), a biopharmaceutical company engaged in the discovery and development of cancer drugs, reported a narrower…

Ticker: RIGL | Exchange: NASDAQ | Report Date: March 3, 2026, after market close Rigel Pharmaceuticals, a specialty pharma company…

Zymeworks Inc. (NASDAQ: ZYME), a Canada-based clinical-stage biotechnology company, on Monday reported a wider net loss for the fourth quarter…

Shares of Medtronic Plc (NYSE: MDT) declined this week, despite the company reporting stronger-than-expected Q3 2026 earnings. Investors were unsettled…

Medical device maker Medtronic Plc (NYSE: MDT) on Tuesday reported stronger-than-expected adjusted earnings for the third quarter of fiscal 2026.…